20/20 Biolabs Common Stock Overview
Valuation check: AIDX's PEG ratio is -0.41, below the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow-0.41
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for AIDX is -0.41. That is below the sector sector average of 10.05. Investors often review this figure alongside 20/20 Biolabs Common Stock's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, AIDX currently prints -0.41 for PEG ratio, while the sector average sits near 10.05. That is roughly 104.1% below the sector mean. Large gaps often invite a closer look at 20/20 Biolabs Common Stock's growth, margins, and balance sheet.
A PEG ratio of -0.41 for 20/20 Biolabs Common Stock is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with AIDX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting AIDX's PEG ratio (-0.41), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
